Agios reported mixed results from a Phase 3 study of its drug Pyrukynd in sickle cell, raising doubts about the drug's ...

In a first-of-its-kind randomized trial, people who smoked weed consumed less alcohol in the two hours afterward than those ...

A federal bankruptcy court judge on Tuesday formally approved OxyContin maker Purdue Pharma’s plan to settle thousands of ...

A unique Harvard program trains future physicians to recognize structural failures embedded within our health care system.

A wave of lawsuits with novel strategies show that the search for Covid vengeance — and jury awards — has gained force under ...

Every physician needs to have a basic level of AI literacy now. That might require some sort of licensing exam.

Instead of hammering on the facts, these public health campaigners in North Dakota have fostered conversation over good food.

Also, we report on some dramatic new childhood vaccine policies that are under consideration, and see how few lower- and ...

Novo Nordisk will soon announce the results of perhaps the most ambitious studies yet of its GLP-1 drug: whether it can help ...

The first randomized controlled trial of the "California sober" approach suggests marijuana may indeed lessen alcohol ...

U.S. health authorities are considering how they might discourage or even ban vaccines that rely on a common ingredient to ...

On Monday, Novo Nordisk announced a discount on its popular drugs for diabetes and obesity, Ozempic and Wegovy, cutting ...